Spectranetics Corp. (NSDQ:SPNC) admitted responsibility and will pay $5 million to avoid federal prosecution in a case alleging the Colorado Springs company illegally imported medical lasers for a clinical trial, according to the U.S. Justice Dept.
The company, which makes cardiac ablation lasers used to zap arterial plaque, agreed to pony up $4.9 million in civil damages and forfeit $100,000 to settle the case, according to the Justice Dept. Spectranetics also agreed to non-prosecution and corporate integrity agreements with the government.